Clinical trial
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
NCT00002689 · Center for Molecular Medicine, Other · Completed
Key facts
| NCT number | NCT00002689 |
|---|---|
| Title | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer |
| Official title | Phase II Interstitial Colloidal 32P Integrated in The Treatment of Non-Resectable Pancreatic Cancer |
| Lead sponsor | Center for Molecular Medicine, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | dexamethasone, fluorouracil, brachytherapy, phosphorus P32, radiation therapy |
| Enrollment | 48 |
| Start date | Sep 1, 1995 |
| Completion | Jun 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: